Vicore Pharma Holding AB

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 0.12, 2.51, 10.82, 0.4, 0.4 ], "ebit_estimate": [ -50.2, -44.78, -54.03, -74.48, -100.52 ], "ebitda_estimate": [ -50.59, -43.8, -52.71, -91.41, -144.21 ], "net_income_estimate": [ -47.6, -41.27, -51.49, -72.68, -99.66 ], "per_share_eps_estimate": [ -0.18, -0.16, -0.14, -0.17, -0.18 ], "eps_nri_estimate": [ -0.18, -0.16, -0.14, -0.17, -0.18 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 0.22, 0.32, 0.41, null, null ], "pretax_income_estimate": [ -51.48, -46.37, -63.26, -72.68, -99.66 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ -51, -52.9, -4.2, null, null ], "roe_estimate": [ -66.3, -100.65, -23, null, null ], "gross_margin_estimate": [ 66.67, 100, 100, 100, 100 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 12.49, "long_term_revenue_growth_rate_mean": "265.40", "future_per_share_eps_estimate_growth": 12.49, "future_eps_nri_estimate_growth": 12.49, "future_revenue_estimate_growth": 265.4, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": 48.73, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 0.06, 0.06, 0.06, null, null, null, null ], "ebit_estimate": [ -13.93, -14.2, -14.82, -13.91, -13.98, -14.05, -14.12 ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ -13.36, -13.69, -14.36, -13.27, -13.44, -13.62, -13.8 ], "per_share_eps_estimate": [ -0.05, -0.05, -0.05, -0.05, -0.05, -0.05, -0.05 ], "eps_nri_estimate": [ -0.05, -0.05, -0.05, -0.05, -0.05, -0.05, -0.05 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -13.36, -13.69, -14.36, -13.27, -13.44, -13.62, -13.8 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 12.49, "long_term_revenue_growth_rate_mean": "265.40", "future_per_share_eps_estimate_growth": 12.49, "future_eps_nri_estimate_growth": 12.49, "future_revenue_estimate_growth": 265.4, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": 48.73, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }